{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:47:58Z","timestamp":1791607678867,"version":"4.3.4"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamaneurol.2019.0648","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:00:53Z","timestamp":1559041253000},"page":"809","source":"Crossref","is-referenced-by-count":117,"title":["Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of <i>APOB<\/i>"],"prefix":"10.1001","volume":"76","author":[{"given":"Thomas S.","family":"Wingo","sequence":"first","affiliation":[{"name":"Division of Neurology, Atlanta Veterans Affairs Medical Center, Decatur, Georgia"},{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza P.","family":"Wingo","sequence":"additional","affiliation":[{"name":"Division of Mental Health, Atlanta Veterans Affairs Medical Center, Decatur, Georgia"},{"name":"Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc-Anh","family":"Le","sequence":"additional","affiliation":[{"name":"Biomarker Core Laboratory, Atlanta Veterans Affairs Medical Center, Decatur, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lah","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi190016r1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease.","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch Neurol"},{"issue":"6","key":"noi190016r2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer\u2019s disease revisited.","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"3","key":"noi190016r3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"1","key":"noi190016r4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng0594-74","article-title":"Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer\u2019s disease.","volume":"7","author":"van Duijn","year":"1994","journal-title":"Nat Genet"},{"issue":"11","key":"noi190016r5","doi-asserted-by":"crossref","first-page":"e1000730","DOI":"10.1371\/journal.pgen.1000730","article-title":"Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.","volume":"5","author":"Chasman","year":"2009","journal-title":"PLoS Genet"},{"key":"noi190016r6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0404.2006.00685.x","article-title":"Cholesterol as a risk factor for Alzheimer\u2019s disease: epidemiological evidence.","volume":"185","author":"Kivipelto","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"issue":"10","key":"noi190016r7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archneurol.2011.203","article-title":"Cholesterol level and statin use in Alzheimer disease, I: review of epidemiological and preclinical studies.","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch Neurol"},{"issue":"3","key":"noi190016r8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E e4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Ann Intern Med"},{"issue":"1","key":"noi190016r9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E e4 allele, and Alzheimer\u2019s disease.","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"issue":"10","key":"noi190016r10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.20.10.2255","article-title":"Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia Aging Study.","volume":"20","author":"Kalmijn","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"noi190016r11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life.","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"noi190016r12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer\u2019s disease: a case-control study.","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"issue":"10","key":"noi190016r13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"},{"issue":"9","key":"noi190016r14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","article-title":"Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"issue":"9242","key":"noi190016r15","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia.","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"noi190016r16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/156720508785132316","article-title":"Reduced risk of incident AD with elective statin use in a clinical trial cohort.","volume":"5","author":"Sparks","year":"2008","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"noi190016r17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000319647.15752.7b","article-title":"Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study.","volume":"71","author":"Cramer","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"noi190016r18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity: the Rotterdam Study.","volume":"80","author":"Haag","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"noi190016r19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajhg.2014.01.009","article-title":"Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.","volume":"94","author":"Peloso","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"2","key":"noi190016r20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MOL.0000000000000159","article-title":"Recent developments in genome and exome-wide analyses of plasma lipids.","volume":"26","author":"Lange","year":"2015","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"noi190016r21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajhg.2014.01.010","article-title":"Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.","volume":"94","author":"Lange","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"3","key":"noi190016r23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer\u2019s Coordinating Center (NACC) database: the Uniform Data Set.","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"noi190016r24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"noi190016r25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12859-016-1453-3","article-title":"MPD: multiplex primer design for next-generation targeted sequencing.","volume":"18","author":"Wingo","year":"2017","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"noi190016r26","doi-asserted-by":"crossref","first-page":"E1923","DOI":"10.1073\/pnas.1618065114","article-title":"PEMapper and PECaller provide a simplified approach to whole-genome sequencing.","volume":"114","author":"Johnston","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"noi190016r28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2010.04.005","article-title":"Pooled association tests for rare variants in exon-resequencing studies.","volume":"86","author":"Price","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"19","key":"noi190016r29","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1093\/bioinformatics\/btu367","article-title":"RAREMETAL: fast and powerful meta-analysis for rare variants.","volume":"30","author":"Feng","year":"2014","journal-title":"Bioinformatics"},{"issue":"3","key":"noi190016r30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants.","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"issue":"7616","key":"noi190016r31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"D1","key":"noi190016r32","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants.","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"noi190016r33","doi-asserted-by":"crossref","first-page":"e60729","DOI":"10.1371\/journal.pone.0060729","article-title":"Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.","volume":"8","author":"Lye","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"noi190016r34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis.","volume":"56","author":"Anstey","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"noi190016r35","doi-asserted-by":"crossref","first-page":"200.e13","DOI":"10.1016\/j.neurobiolaging.2016.02.024","article-title":"Assessment of the genetic variance of late-onset Alzheimer\u2019s disease.","volume":"41","author":"Ridge","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"5","key":"noi190016r36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease.","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"noi190016r37","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74 046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease.","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"noi190016r38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease.","volume":"43","author":"Naj","year":"2011","journal-title":"Nat Genet"},{"issue":"5","key":"noi190016r39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng.3246","article-title":"Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease.","volume":"47","author":"Steinberg","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"noi190016r40","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/pr7006329","article-title":"Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice.","volume":"7","author":"Bereczki","year":"2008","journal-title":"J Proteome Res"},{"issue":"10","key":"noi190016r41","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.neurobiolaging.2013.04.008","article-title":"Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice.","volume":"34","author":"L\u00f6ffler","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"1","key":"noi190016r42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.32499","article-title":"Genomic variants, genes, and pathways of Alzheimer\u2019s disease: an overview.","volume":"174","author":"Naj","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"noi190016r43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"Mendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"noi190016r27","author":"Kotlar","year":"2018"},{"key":"noi190016r22","unstructured":"National Alzheimer\u2019s Coordinating Center. Description of NCAA database. https:\/\/www.alz.washington.edu\/WEB\/data_descript.html. Accessed April 10, 2018."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/7\/809\/17684644\/jamaneurology_wingo_2019_oi_190016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T11:01:25Z","timestamp":1562583685000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2019.0648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.0648","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}